Name | 4,7-dihydroxy-1-[(E)-4-hydroxy-3,5-dimethyl-8-phenyloct-7-enyl]-6-[(6E,12E)-tetradeca-6,12-dienoyl]oxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid |
---|---|
Synonyms | Zaragozic acid B |
Description | Zaragozic acid B, a fungal metabolite, is a potent inhibitor of both farnesyl-protein transferase (FPTase) and squalene synthases. Zaragozic acid B is a potential anticancer drug[1]. |
---|---|
Related Catalog | |
In Vitro | Zaragozic acid B is a very potent inhibitor of squalene synthases from all three sources (RSS: rat liver microsome; YSS: Candida albicans; HSS: Hep G2 cells) with the IC50 values range from 0.22 to 0.67 nM[1]. Zaragozic acid B inhibits bovine FPTase (IC50=100 nM), human FPTase (IC50=185 nM)[1]. |
References |
Density | 1.3g/cm3 |
---|---|
Boiling Point | 871.6ºC at 760mmHg |
Molecular Formula | C39H54O13 |
Molecular Weight | 730.83800 |
Flash Point | 260.4ºC |
Exact Mass | 730.35600 |
PSA | 217.35000 |
LogP | 4.87800 |
Vapour Pressure | 0mmHg at 25°C |
Index of Refraction | 1.593 |